* Cross Country Healthcare Inc CCRN.OQ CCRN.O is
expected
to show a fall in quarterly revenue when it reports results on
August 2.
* The Boca Raton Florida-based company is expected to
report a
29.4% decrease in revenue to $531.68 million from $753.56
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on May
3 2023, for the period ended June 30, was for revenue between
530.00 million and 540.00 million.
* Refinitiv's mean analyst estimate for Cross Country
Healthcare
Inc is for earnings of 61 cents per share. The company's EPS
guidance on May 3 2023, for the period ended June 30, was
between 0.55 and 0.65
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cross
Country
Healthcare Inc is $30, above its last closing price of $25.80.
The company's guidance on May 3 2023 for the period ended June
30 was for Earnings before Interest, Taxes, Depreciation and
Amortization of between 530 million and 45 million.The company's
guidance on May 3 2023 for the period ended June 30 was for
gross profit margin between 22.5% and 23%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.75 0.75 0.84 Beat 12.4
Dec. 31 2023 0.89 0.89 1.09 Beat 21.9
Sep. 30 2022 0.96 0.95 1.07 Beat 12.6
Jun. 30 2022 1.35 1.35 1.40 Beat 3.8
Mar. 1.34 1.31 1.70 Beat 29.3
31 2022
Dec. 31 2021 1.30 1.24 1.40 Beat 12.6
Sep. 30 2021 0.34 0.34 0.61 Beat 77
Jun. 30 2021 0.40 0.40 0.47 Beat 18.7
This summary was machine generated August 1 at 00:25 GMT. All
figures in US dollars unless otherwise stated